Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis

Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis

This article considers the relevance of treating psoriatic arthritis with genetically engineered drugs such as adalimumab and secukinumab. Also, it conducts retrospective analysis of the medical history of the patient, who had this therapy.

Bibliographic Details
Main Authors: V. V. Didenko, G. A. Kalashnik, Ju. Ju. Karpenko, E. N. Harlamova
Format: Article
Language:Russian
Published: SINAPS LLC 2021-05-01
Series:Arhivʺ Vnutrennej Mediciny
Subjects:
psoriatic arthritis
genetically engineered drugs
adalimumab
secukinumab
Online Access:https://www.medarhive.ru/jour/article/view/1239

Similar Items

Similar Items